Enter PCMag.com's Readers' Choice/Business Choice Survey sweepstakes for a chance to win!
- BusinessInsider Monkey
Hedge Funds Have Never Been More Bullish On Alector, Inc. (ALEC)
Given their 2 and 20 payment structure, hedge funds have more incentives and resources than the average investor. Like everyone else, hedge funds perform miserably at times, but their consensus picks have historically outperformed the market after risk adjustments. Hedge fund interest in Alector, Inc. (NASDAQ:ALEC) shares was flat at the end of last quarter.
- BusinessAssociated Press
Vera Bradley: Fiscal 3Q Earnings Snapshot
The Roanoke, Indiana-based company said it had profit of less than 1 cent on a per-share basis. Earnings, adjusted for non-recurring costs, were 20 cents per share. The handbag and accessories company posted revenue of $127.5 million in the period.
- BusinessInsider Monkey
Is Avista Corp (AVA) A Good Stock To Buy ?
That's why we believe it isn't a waste of time to check out hedge fund sentiment before you invest in a stock like Avista Corp (NYSE:AVA). Avista Corp (NYSE:AVA) shareholders have witnessed an increase in support from the world's most elite money managers of late. AVA was in 15 hedge funds' portfolios at the end of the third quarter of 2019.
- BusinessYahoo Finance Video
Costco pops after releasing first-quarter results
Yahoo Finance's Seana Smith breaks down Costco's first-quarter earnings results live.
- BusinessFX Empire
European Equities: A Tory Victory and A U.S – China Trade Agreement!
Friday, 13th December 2019 Spanish CPI (YoY) (Nov) Final Spanish HICP (YoY) (Nov) Final The Majors It was another bullish day for the European majors, which saw green for a 2nd consecutive day, with the DAX30 rising by 0.57% to lead the way. The CAC40 and EuroStoxx600 weren't far behind with gains of 0.40% and 0.33% respectively. Twitter delivered the upside on the day, with a Trump tweet late on Thursday announcing that a trade deal was close leading to a broad-based market rebound.
- NewsAmerican City Business Journals
In an about face, FDA approves Sarepta's 2nd Duchenne drug
After the drug was originally rejected by the FDA in August due to concerns over the risk of infection at the infusion site and renal toxicity, the company filed an appeal. The company said that "the matters raised in the CRL were rapidly evaluated and resolved by Dr. Peter Stein, director of the office of new drugs," after which an application was resubmitted. Vyondys 53, like Sarepta's first commercial treatment Exondys 51, was developed to skip over a specific gene mutation that prevents young boys with the disease from producing a protein called dystrophin, which is vital to muscle health.
- BusinessBloomberg
Apple Avoids $150-Per-iPhone Levy After U.S., China Reach Deal
Apple Inc. avoided 15% tariffs on its most important products, the iPhone, iPad and MacBooks, after U.S. President Donald Trump signed off on a trade deal with China. The new import duties were due to kick in Dec. 15 and could have added about $150 to the price of iPhones during the crucial holiday shopping season, according to Wedbush Securities analyst Dan Ives. “Trump delivered an early Christmas present to Apple,” Ives wrote in a note to investors following news of the trade deal.
- FinanceUSA TODAY
'I have no idea of how I'm getting home': Truckers struggle after Celadon bankruptcy
Bo Wells was sitting inside his truck at a Pilot travel center in Dallas on Monday, waiting for management at Celadon Group Inc. to give him instructions on where to drop off his company-owned truck. "The shutdown has caused a lot of confusion and aggravation to say the least," Wells wrote in a Facebook message.
- BusinessReuters
China retaliatory tariffs cost billions in lost consumption: study
Tariffs slapped by China on U.S. products cost the most affected communities billions of dollars in lost auto sales in 2018 as the hit to local incomes undercut household spending, according to an analysis released on Wednesday by the National Bureau of Economic Research. "Changes in trade policy had large effects on consumption," wrote Waugh, who analyzed county-level auto sales data before and after China retaliated against U.S. tariffs by imposing levies of its own, most notably on U.S. grown soybeans and pork. The counties most exposed to tariffs, notably those in the agricultural Midwest, had auto sales roughly 2.5 percentage points lower than in counties whose local economies were less exposed to Chinese retaliation.
- BusinessGuruFocus.com
Michael Burry's Top 5 Holdings
GuruFocus warns that GameStop's operating margin have declined approximately 9.8% per year on average over the past five years, while revenues have declined approximately 2.60% per year on average over the past three years. The company's three-year revenue decline rate underperforms 66.74% of global competitors. CEO George Sherman said prevailing industry trends, which included the "unprecedented decline in new hardware sales," contributed to the revenue decline.
- BusinessInsider Monkey
A Better Dividend Stock Than Exxon Mobil, Altria, Universal and National Fuel
Dividend investors usually focus on companies that have a long track record of increasing their dividends year after year. The companies with at least 25 years of consecutive dividend increases are especially favored by income oriented investors. In these situations, the losses due to share price decline might wipe out the dividend income that has been collected over the years.
- BusinessBloomberg
Elliott’s PG&E Plan Aims Carefully at Gavin Newsom
Newsom must decide whether to support the company's latest plan to emerge from chapter 11, which includes a revised $13.5 billion settlement agreed last week with wildfire victims. Having also settled with insurance firms for $11 billion and local governments for $1 billion, PG&E has effectively tightened pressure on one of the last remaining stakeholders — sitting in Sacramento — to get on board. In the background, a clock ticks toward the effective June 2020 deadline enshrined in California's wildfire-fund legislation.
- FinanceAmerican City Business Journals
The buildings Jacksonville lost in 2019
Historic preservation netted some major wins in Jacksonville in 2019. The $53 million renovation of the Barnett building crossed the finish line, the $15 million renovation of the Ambassador Hotel is underway and the long-vacant Independent Life building will be resurrected next year. City Hall annex and courthouse Environmental Holdings Group LLC won an $8 million contract to demolish both the former city hall annex at 220 E Bay St. and the old courthouse at 330 E. Bay St. The demolitions, carried out in January, were initially planned by the city and the Downtown Investment Authority to make room for a new convention center, though plans for a convention center were later halted.
- BusinessYahoo Finance Video
General Electric climbs after UBS upgrade
GE shares are climbing after UBS upgraded the stock to a 'buy' and raised its price target. Yahoo Finance's Brian Cheung joins Seana Smith on The Ticker to discuss.
- BusinessInsider Monkey
Is Chesapeake Energy Corporation (CHK) Going To Burn These Hedge Funds ?
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good. This year hedge funds' top 20 stock picks easily bested the broader market, at 37.4% compared to 27.5%, despite there being a few duds in there like Berkshire Hathaway (even their collective wisdom isn't perfect). Chesapeake Energy Corporation (NYSE:CHK) shareholders have witnessed a decrease in hedge fund sentiment recently.
- BusinessSimply Wall St.
Are Insiders Buying SmileDirectClub, Inc. (NASDAQ:SDC) Stock?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So before you buy or sell SmileDirectClub, Inc.
- BusinessInsider Monkey
Did Hedge Funds Drop The Ball On Axsome Therapeutics, Inc. (AXSM)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. In this article, we analyze how these elite funds and prominent investors traded Axsome Therapeutics, Inc. (NASDAQ:AXSM) based on those filings. The number of bullish hedge fund bets went down by 1 lately.
- WorldYahoo Finance UK
Pound rockets by 2% as exit poll predicts big Conservative win
The pound surged against the US dollar (GBPUSD=X) on Thursday night, after an exit poll for the 2019 general election predicted a thumping victory for the Conservative Party. An exit poll released at 10pm on Thursday forecast the Conservative Party will win 368 seats in parliament, well above the 326 needed to form a government. A win for Boris Johnson's party means Britain will likely officially leave the EU at the end of January and move on to the next stage of negotiations.
- BusinessAmerican City Business Journals
NuScale checks off another box in small modular reactor review
NuScale Power's small modular reactor is a step closer to getting a federal stamp of approval. The Oregon company — headquartered in Tigard, with technical staff in Corvallis — said Thursday that U.S. nuclear regulators closed the fourth phase of a six-phase design certification process that began nearly three years ago. This is the first time the Nuclear Regulatory Commission has reviewed a small modular reactor.
- BusinessInsider Monkey
Hedge Funds Have Never Been More Bullish On Kadmon Holdings, Inc. (KDMN)
Interest rates are paused at very low levels, and the risk of significant increases in the medium term seems low. Brookfield was right about politics as stocks experienced their second worst May since the 1960s due to escalation of trade disputes. Hedge fund interest in Kadmon Holdings, Inc. (NYSE:KDMN) shares was flat at the end of last quarter.
- BusinessSimply Wall St.
Trade Alert: The Chief Scientific Officer Of Sage Therapeutics, Inc. (NASDAQ:SAGE), Albert Robichaud, Has Just Spent US$1.6m Buying Shares
Sage Therapeutics, Inc. (NASDAQ:SAGE) shareholders (or potential shareholders) will be happy to see that the Chief Scientific Officer, Albert Robichaud, recently bought a whopping US$1.6m worth of stock, at a price of US$64.16. Notably, that recent purchase by Albert Robichaud is the biggest insider purchase of Sage Therapeutics shares that we've seen in the last year. You can see the insider transactions (by individuals) over the last year depicted in the chart below.
- BusinessSimply Wall St.
Chewy, Inc. Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
Losses were smaller than analysts expected, coming in at US$0.20 per share. Analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Taking into account the latest results, the latest consensus from Chewy's eleven analysts is for revenues of US$6.23b in 2021, which would reflect a major 36% improvement in sales compared to the last 12 months.
- BusinessInsider Monkey
Is ASML Holding N.V. (ASML) A Good Stock To Buy ?
Is ASML Holding N.V. (NASDAQ:ASML) a splendid investment now? Prominent investors are becoming more confident. The number of long hedge fund bets improved by 3 recently.
- BusinessSmarterAnalyst
Here’s Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today
Investors love healthcare stocks for the lottery ticket-like returns they can offer if a company strikes medical gold or wins the FDA's blessing. Case in point: Amneal Pharmaceuticals (AMRX), whose shares are jumping nearly 50% on Thursday, on the back of FDA approval for EluRyng, the first generic NuvaRing. NuvaRing is a flexible, transparent ring that contains the hormones estrogen and progestin to prevent an unwanted pregnancy.
- BusinessInsider Monkey
Is Grocery Outlet Holding Corp. (GO) A Good Stock To Buy?
That's why we believe it isn't a waste of time to check out hedge fund sentiment before you invest in a stock like Grocery Outlet Holding Corp. NASDAQ:GO). Grocery Outlet Holding Corp.
